HEALTHCARE INDUSTRY ASSOCIATION (HCIA) RESUME BOOK Columbia Healthcare and Pharmaceutical Management Program

CLASS OF 2016 CLASS OF 2017

CONTENTS

2016 RESUMES 12 SYLVIA QIU 21 AMANDA EVANS TANYA RANA DAVID FARKAS 3 ANNE LISE ALMIRA JESSICA H. ROE PAWEL FEDEJKO CARL BALOUZIAN AVIVA BORTNIKER 13 ERIC SCHNIPPER 22 EMILY GARVIN STEPHANIE SCHREIBER RACHEL J. HAN 4 AUGUSTINE BOURNE SHIJIA (GRACE) SHEN CAROLYN HEISLER VICTORIA BRESNAHAN LIZA COBURN 14 NATALIE SUTTON 23 FRANCES HOU COLIN THIMONS MISHA IPATOV 5 BENJAMIN CRAMER HARSH TIWARI HILLARY KAPLAN IANA DIMKOVA SARAH DREW 15 MARK VILLANUEVA 24 JONATHAN KIM ANDREA WANG VICTORIA LAI 6 MICHAEL HAJATIAN ZHI YANG YULING LEE SARAH HERSH ADRIENNE HOWELL 16 NEJAT ZEYNELOGLU, MD 25 JAMIE MEYERSON NICHOLAS MORGAN 7 TRISTAN HUNT J.T. MUNCH JESSICA KLEINER 2017 RESUMES 26 RICHARD MURPHEY TIMOTHY KOO 16 LISA AULT SAM NELSON CARLY BIGI 8 JOSEPH KUHNS ADAM NORRIS JAMES J. LEE 17 ZACHARY BOGNER 27 SEAN PARK ROMAN LESKO BROOKE A. BONET VARNA RAMAN GUIDO CASTAGNOLA, MD 9 JONATHAN LICHTINGER BLAKE RICHARDS C. ADELE MAASS 18 CECE CHEN 28 ZOE SANSTED ELENA MAYER BRANDON CHEONG MORGAN SHATTUCK JAMES CHEUNG 10 GEOFF MCGRANE XIN (TONY) SHU SRISHTI MIRCHANDANI 19 KEVIN COLLINS 29 BRYAN SONG DONNA MORDENTE ELIZABETH COLONNA JULIAN TING GAURAV DAYAL 11 LINDSEY MURRAY JOYCE YUE XU DILBER S. MUTLU 20 DANIELA DUKES KOMAL PATEL CHRISTIAN DUNNE LEV ELDEMIR HCIA AT COLUMBIA BUSINESS SCHOOL

The Healthcare Industry Association (HCIA) is committed to expanding opportunities outside of the classroom for Columbia Business School students to learn about the many segments of the healthcare industry. Working in close collaboration with the Healthcare and Pharmaceutical Management Program, HCIA organizes a variety of activities throughout the year. It offers members the opportunity to increase their knowledge of the healthcare industry, expand their professional networks, learn about diverse career paths, and secure internships, full-time opportunities, and in-semester projects. The healthcare-related activities broaden students’ exposure to global healthcare practice and complement the learning that occurs in the classroom. Students interact regularly with leading industry practitioners, many of whom are alumni, through experiential learning opportunities and programming. The following events are offered throughout the year:

Columbia Business School Annual Healthcare Conference Healthcare Career “Supercharger” Career Bootcamp Series “Day in the Life” Events with select corporate partners Lunch and Learn Networking Events Alumni Networking Events Executive Speakers Peer-to-Peer groups with Social Enterprise, Entrepreneurship, Value-Investing, and others

HCIA members accept full-time and internship positions across the spectrum of the healthcare industry. Many students are recruited into management development rotation programs and functional positions (finance, marketing, business development, strategic planning, etc.) at global healthcare enterprises and early-stage life sciences and healthcare services companies. Students also obtain healthcare-focused positions in consulting, investment banking, private equity/venture capital, and nonprofit organizations.

2015 – 2016 HCIA Resume Book 1 HEALTHCARE AND PHARMACEUTICAL MANAGEMENT PROGRAM

Columbia Business School’s Healthcare and Pharmaceutical Management (HPM) Program provides students with a real-world understanding of the increasingly complex healthcare environment. Through a multidisciplinary approach shaped by innovative course offerings, complementary out-of-class activities, networking opportunities with industry leaders, and one-on-one career planning/mentoring, the Program offers a dynamic learning experience focused on the major issues affecting the global health- care ecosystem. The HPM Program emphasizes critical thinking and encourages the development of new approaches to address the strategic, economic, competitive, technological, and sociopolitical challenges facing this important sector. Healthcare courses are offered as electives (no minimum requirements) within the overall curriculum at Columbia Business School, enabling students to tailor their coursework to their individual needs and career aspirations. The HPM Program offers students: A flexible, comprehensive, and pragmatic array of healthcare courses A career-focused approach to learning and professional development A powerful network of alumni and other healthcare business professionals A global perspective An entrepreneurial mindset An attractive New York City location Access to the world-class Columbia healthcare community The HPM Program was established in 2006 and is currently led by Lorraine Marchand, who brings over 20 years of healthcare experience to Columbia Business School with executive roles in the public, private, and start-up sectors. The Program was designed by seasoned industry executives who understand first-hand the skills and industry insight necessary to be successful in this dynamic and highly challenged global business sector. Healthcare electives build on the MBA Program’s rigorous core-curriculum and are designed and taught by a unique mix of experienced industry executives and prominent CBS faculty. They cover each major healthcare sector (biopharmaceuticals, medical devices and diagnostics, healthcare services, and healthcare information technology) on a global basis, from both industry and investor perspectives. Additionally, all functional areas are covered: strategy, management, marketing, finance, business development, M&A, risk management, operations, and policy. The Program helps students successfully pursue careers in pharmaceuticals, biotechnology, medical devices & diagnostics, healthcare services/HCIT, management consulting, investment banking, equity research, venture capital, private equity, and entrepreneurship. Information on the HPM Program can be found at: www8.gsb.columbia.edu/healthcare/ 2016 : Almira – Bortniker

ANNE LISE ALMIRA CARL BALOUZIAN AVIVA BORTNIKER [email protected] [email protected] [email protected] Management and Operations Private Equity and Corporate Development Management and Strategy Yale School of Public Health Colgate University Cornell University New Haven, Connecticut Hamilton, New York Ithaca, New York MPH, Health Administration, 2010 BA, Economics, 2007 BS, Industrial & Labor Relations, 2009 Vassar College Poughkeepsie, New York GREY MOUNTAIN PARTNERS, PFIZER, New York, NY BS, Economics, German Studies, 2006 Boulder, CO Summer Marketing Associate, US Vaccines Summer Associate 2015 2015 VERTEX PHARMACEUTICALS, Led feasibility analysis of electronic health Boston, MA Evaluated investment opportunities record pilot; collaborated to develop Summer Intern, Corporate & Business across multiple sectors, including health- cross-functional implementation process. Development care, transportation (through IOI), and Designed quantitative/qualitative model to 2015 manufacturing. prioritize US geographic areas based on Evaluated potential business development Assisted in pursuing an add-on acquisition market opportunities. (BD) targets through financial and pipeline for a portfolio company in the commercial Evaluated analytic reports on current analyses to ensure strategic alignment glass manufacturing sector. patient vaccine adherence program; crafted with Vertex’s long-range growth plan. Completed a business development alternative mobile initiatives and account Identified and documented important drug analysis for a portfolio company in the targeting to increase patient access and development criteria for a more robust electrical equipment sector. compliance. assessment of a company’s pipeline strength using their clinical trial data. CANTOR FITZGERALD & CO., DELOITTE CONSULTING, New York, NY New York, NY Consultant (2012 – 2014) DANBURY HOSPITAL, Danbury, CT Healthcare Investment Banking Analyst (2011 – 2012) Finance & Grants Management Specialist Vice President (2014) Project managed HR components of a 2013 – 2014 Associate (2011 – 2014) global pharmaceutical client’s M&A/ Analyzed department financial data for the Executed financing (public/private), divestiture transactions; planned and development and execution of business M&A, and restructuring advisory transac- implemented HR consequences from five plans for hospital management as part of tions across healthcare services, medical deals, covering staff in 60+ countries; the department’s five-year, $10m plan for devices, molecular diagnostics, specialty contact point for consulting team, set in expansion. pharma, and biotechnology sectors. four international regions. Managed four federal & private grant Performed several types of analyses for Conducted HR current state assessment awards totaling $7m. existing and prospective clients, including for a hospital system’s 43 facilities across valuation analyses, models demonstrating six states, developed a new HR operating Graduate Medical Education Coordinator the pro forma effects for various forms of model, and built a three-year business 2012 – 2013 financings, and mergers and acquisitions. plan with projected $10m cost savings. Pioneered collaboration with 12 residency Supervised and managed multiple analysts Developed M&A playbook for a global program coordinators and physicians during live transactions, pitches, and pharmaceutical client’s standardized through education of budget ownership internal projects. approach for future transactions. and communication of program expenses, Supported a global health insurance leading to more accurate residency GLEACHER & COMPANY SECURITIES, INC., carrier’s HR outsourcing program. program cash flows. New York, NY Healthcare Investment Banking Clinical Research Associate NEW YORK LIFE INSURANCE COMPANY, Associate (2011) New York, NY 2011 – 2012 Analyst (2007 – 2010) Created and maintained ledger to track office Rotational Program Completed over 20 transactions consisting 2009 – 2010 cash flows of $10k per month. of M&A advisory, restructuring advisory, Executed HR services to 150-person private/public equity, and fixed income client group, including compensation, financings. organizational effectiveness, and employee mediation. 2015 – 2016 HCIA Resume Book 3 2016 : Bourne – Drew

AUGUSTINE BOURNE VICTORIA BRESNAHAN LIZA COBURN [email protected] [email protected] [email protected] Business Development and Management Marketing and Strategy Consulting and Strategy BPP Law School Columbia University Duke University London, United Kingdom New York, New York Durham, North Carolina GDL/LPC, Law, 2007 BA, History, 2010 BS, Chemistry, 2010 University of Oxford Oxford, United Kingdom PFIZER, New York, NY PWC STRATEGY&, New York, NY Master’s (M.Biochem.), Molecular and Summer Associate Senior Associate Summer Intern Cellular Biochemistry, 2005 2015 2015 Performed strategic analysis and Drove recommendations for a leading GILEAD SCIENCES, Foster City, CA developed global brand strategy to industry association on the future of Summer Intern, US Oncology Marketing improve brand performance. specialty pharmaceutical distribution by 2015 Identified revenue and margin quantifying the incremental cost to the healthcare system from manufacturer- Developed strategic insights and tactical maximization initiatives. direct distribution. programs as part of brand team for Zydelig ROSETTA CONSULTING, New York, NY (idelalisib), a first-in-class PI3K-delta DAIICHI SANKYO, Parsippany, NJ inhibitor with three hem-onc indications. Senior Associate Consultant (2013 – 2014) Associate Consultant (2012 – 2013) Senior Analyst, Thrombosis Market Research 2013 – 2014 THAR PHARMACEUTICALS, New York, NY Delivered marketing strategy consulting Business Development & Licensing Intern services to healthcare clients, including Created a multi-phase segmentation study 2014 – 2015 strategic planning, growth opportunity to identify target patient population for a product launch and provide foundation for Assisted CEO of clinical-stage specialty assessments, product launch optimization, all subsequent launch planning of patient pharmaceutical company with corporate and ongoing strategic support. promotion. partnering efforts. Created a new value proposition for strug- Nominated and selected to direct a cross- Performed comp analysis of business gling healthcare product and collaborated functional committee of senior leadership development and licensing transactions in with cross-functional client teams and tasked with managing the P&L of the the orphan drug space. advertising partners to develop platforms and digital roadmap to communicate company’s four product franchises to WEIL, GOTSHAL & MANGES, New York, NY new messages. ensure collaboration and innovation. and London, United Kingdom Formulated strategy to improve continuity Associate, Commercial Operations Rotation Associate, Capital Markets of care for a drug initiated in the hospital (Marketing, Market Research, Supply Chain) 2009 – 2014 by leveraging digital tools and services to 2010 – 2013 Advised companies and private equity enhance stakeholders’ ability to manage Facilitated “Shark Tank” innovation forum firms on corporate and finance transactions, care in the outpatient setting. where colleagues pitched ideas to brand including IPOs and acquisitions. Executed Managed quantitative and qualitative managers; $1.2m investment committed. 12 transactions ($4.5b by value) in final market research studies, including 18 months. Spearheaded an initiative with a national ATU, patient chart audit, message testing, retail pharmacy to develop innovative Led cross-functional deal teams, prepared and concept testing, and presented disease education at the point-of-sale to investor materials, and negotiated high- recommendations to brand leads. improve patient adherence. value corporate and commercial contracts. Built quantified treatment flow model that Re-engineered the suboptimal distribution Achieved top ranking performance defined patient journey for disease state of product samples to 1,500 sales repre- assessments every year. and highlighted opportunities for client to sentatives nationwide by driving system increase usage at each decision point. changes and educating key internal stake- holders on the business issues.

4 2015 – 2016 HCIA Resume Book BENJAMIN CRAMER IANA DIMKOVA SARAH DREW [email protected] [email protected] [email protected] Operations and Technology Private Equity and Finance Entrepreneurship and Private Equity University of Maryland Columbia University Cornell University College Park, Maryland New York, New York Ithaca, New York BS, Aerospace Engineering, 2007 BA, Political Science, 2006 BS, Operations Research & Information Engineering, 2010 BDO USA, LLP, New York, NY GE VENTURES, Menlo Park, CA Summer Associate, Healthcare Advisory Summer Associate RED SEA VENTURES, New York, NY 2015 2015 Summer Associate Collaborated with multi-disciplinary Prospected for new investment 2015 consulting team to create new business opportunities, conducted due diligence, Sourced and evaluated potential seed- development proposals, assess key market and prepared investment memoranda stage investment opportunities through trends, and develop strategies for major for GE’s venture capital fund focused on founder meetings and analysis of market hospital system clients coping with changes healthcare sector. dynamics, competitive landscape, growth in health policy and reimbursement. potential, and investment criteria. ALVAREZ & MARSAL, New York, NY Designed expense allocation models for Associate, Healthcare Industry Group COHEROHEALTH, New York, NY hospitals to understand the cost of 2013 – 2014 Business Development Intern different operational areas, and prepared 2015 other financial analyses and models to Provided financial and operational forecast business performance. improvement advisory services to health- Analyzed industry data to design care providers and financial sponsors. commercialization strategy for integrated INTELSAT, S.A., Washington, DC Performed due diligence and developed respiratory care management mobile Senior Satellite Systems Engineer (2012 – and implemented performance improve- platform. 2014) ment plans focused on transaction cycle Conducted market research and ROI Satellite Systems Engineer (2010 – 2012) time reduction, sales force build out, and analyses to assess value propositions for Associate Satellite Systems Engineer resource rationalization for private equity- target customers. (2009 – 2010) backed portfolio companies. Led time-critical recovery operations for THE BLACKSTONE GROUP, New York, NY serious satellite anomalies. PROCURE TREATMENT CENTERS, INC., Investment Operations Analyst, Blackstone New York, NY Alternative Asset Management Monitored satellite health and operations, Manager, Business Operations and Project 2012 – 2014 and optimized the performance and Finance Groups reliability of spacecraft from multiple Advised Portfolio Management team on 2008 – 2013 manufacturers. hedge fund investment allocation decisions Led deal teams that partnered with by analyzing manager liquidity and Designed, developed, and implemented medical institutions and physicians to performance, and investment mandate, software solutions to automate various develop proton therapy cancer demand, and asset type. processes, including complex procedure treatment facilities. language conversions, limit alarm updates, OPPENHEIMER & CO. INC., New York, NY Secured strategic equity investments by and maneuver plan management tools. Analyst, Healthcare Investment Banking conducting due diligence, drafting project 2010 – 2012 Defined and developed satellite system memoranda, negotiating and structuring and subsystem requirements for a new joint-venture agreements, and analyzing Researched and generated industry ground system while creating test plans clinical opportunities and financial returns. overviews for several healthcare sub- and conducting thorough acceptance tests. sectors with a focus on healthcare IT and Managed performance-improvement 24/7 on-call response duties (one week payer/provider technology-enabled initiatives through process analysis and solutions. per month) to address immediate satellite benchmarking within intake, financial needs. management, and treatment planning Developed financial models and performed departments. valuation analyses to support strategic recommendations.

2015 – 2016 HCIA Resume Book 5 2016 : Hajatian – Koo

MICHAEL HAJATIAN SARAH HERSH ADRIENNE HOWELL [email protected] [email protected] [email protected] Management and Strategy Strategy and Consulting Consulting University of Maryland The Johns Hopkins University Emory University College Park, Maryland Baltimore, Maryland Atlanta, Georgia BA, Finance, 2008 BA, Writing Seminars, Psychology, 2011 BBA, Finance, 2010

JANSSEN BIOTECH, Horsham, PA EPIC SYSTEMS, Madison, WI NEWYORK-PRESBYTERIAN HOSPITAL, Senior Analyst, Pricing Strategy Implementation Director New York, NY 2012 – 2014 2014 Graduate Intern, Operations Evaluated investment decisions for all Led 11-month upgrade engagement for 2015 distributor, payer, and provider pricing six-hospital health system spanning three Developed and implemented management strategies establishing greater access and states and 26 counties. best practices to decrease incremental affordability for biologic portfolio; Analyzed upgradeable software components nursing staff overtime through an initial pilot ~$3b in spend. for financial impact and created a strategic and subsequent roll-out across all units at Developed share, revenue, and cost project plan. The Allen Hospital, which resulted in a 12% decrease of overtime incidents. projections using market analysis to assess Communicated expectations, coordinated potential “Deal or No Deal” scenarios and solutions to internal problems, and delivered WELLS FARGO & COMPANY, Multiple calculate ROI. project results to hospital executives. US Locations Established fluency in public policy Application Coordinator Relationship Manager, Commercial Real Estate effecting industry in order to communicate 2012 – 2014 2013 – 2014 financial implications resulting from key Served as lead underwriter in a three-person legislation and reform. Delivered technology focused strategies to improve hospital workflows and executed deal team for high profile ($80-$200m) construction and long-term loans to New DEPUY MITEK, Raynham, MA these strategies through software York-based private commercial real estate Analyst, Operations Finance implementation. developers. 2010 – 2011 Owned front-end software implementation Managed US inventory movements, scrap success for one project in a California Managed the closing of 3+ transactions, and disposals, and physical inventory children’s hospital and one in a seven- including loan approval, valuation analysis, adjustments in compliance with Johnson & hospital Boston area health system. loan document negotiation, and credit investigations. Johnson worldwide policy – ~$24m. Researched best practices to create an Identified root cause of 65% of customer Improving Cash Collection conference Associate, Credit Management Training Program returns relating to five products. session and presented to 200 industry 2012 – 2013 Collaborated with Operations to develop leaders at a financial conference. Selected for five month advanced credit communication strategy for physician Developed a subsequent operational training program in San Francisco, CA; training and education. handbook that increased cash collection enhanced credit underwriting, client by over 25% on average. relationship management, and business JOHNSON & JOHNSON, New Brunswick, NJ Collected workflow data and key development skills. Graduate, Financial Leadership Development performance indicators, then analyzed Financial Analyst, Commercial Bank Program this data to support and inform workflow 2010 – 2012 2008 – 2011 recommendations. Underwrote 10+ new deals to middle-market Managed financial planning and analysis companies (annual revenues of $20-$500m) for global budgets in both Corporate and and supported several senior level managers Medical Device sectors. in due diligence and financial analysis across two offices in Atlanta, GA during a time of double-digit loan growth.

6 2015 – 2016 HCIA Resume Book TRISTAN HUNT JESSICA KLEINER TIMOTHY KOO [email protected] [email protected] [email protected] Consulting and Entrepreneurship Strategy and Management Management and Private Equity Columbia University College of Cornell University Duke University School of Medicine Physicians and Surgeons Ithaca, New York Durham, North Carolina New York, New York BS, Industrial & Labor Relations, 2010 MD, 2011 MD, 2016 Princeton University University of Notre Dame TIAA-CREF, New York, NY Princeton, New Jersey Notre Dame, Indiana Corporate Strategy & Development AB, Molecular Biology, 2006 BS, Pre-Professional Studies, 2010 Summer Associate 2015 MOUNT SINAI HEALTH SYSTEM, COLUMBIA HEARTSOURCE, New York, NY Conducted competitive market analysis New York, NY Consultant to inform firm-wide Diversity & Inclusion Attending Physician, Department of 2015 – Present strategy refresh; identified bottom-line Emergency Medicine impact on business objectives. Evaluated existing business model and 2014 – Present product offerings for Columbia-affiliated Designed streamlined model for the Serve as front-line physician in an urban, cardiac management service organization. Diversity & Inclusion organization; defined tertiary care Level 1 Trauma Center. key interaction points and roles and Developed strategy to accelerate profitable Clinical instructor and academic mentor responsibilities. growth focused on scalable products for emergency medicine residents and leveraging scarce senior resources. Presented findings and recommendations Mount Sinai medical students. to Chief Diversity Officer and Chief Head of the residency’s Journal Club HEALTH TECHNOLOGY ASSEMBLY, Strategy Officer. curriculum, teaching statistics, and New York, NY the proper interpretation of research Fellow DELOITTE CONSULTING, New York, NY studies and other medical literature. 2015 – Present Consultant (2012 – 2014) Analyst (2010 – 2012) Directed community of collaboration MCKINSEY & COMPANY, New York, NY between clinicians, engineers, and Managed international team of 10 Deloitte Summer Associate entrepreneurs across Columbia. US India practitioners to analyze training 2015 needs for global, multi-functional Tested and revised payment models, and ECONOMIC ANESTHESIOLOGY shared services center supporting seven designed clinical pathways for inclusion in RESEARCH, New York, NY departments and achieved over 15% in state Medicaid demonstration project on Contributor cost savings. payment innovation. 2014 – 2015 Led process design workshops for global Designed operating model for creation of Led evaluation of economic costs of pharmaceutical organization and redesigned medical software solutions for Fortune 500 anesthesia-related labor and delivery 40 business processes implemented in pharmaceutical company. complications in New York. client’s future state service delivery model. Prepared original manuscript for Modeled and validated functional publication and presentation. synergies across 11 departments, identifying estimated savings of $62m+ over four INTERVOL, Leogane, Haiti years resulting from corporate acquisition. Field Coordinator 2010 – 2011 Led functional integration of standalone subsidiary into global pharmaceutical Transitioned a post-earthquake recovery organization across 26 countries and five program to a sustained visiting medical workstreams. and surgical program. Coordinated over 50 medical professionals from Haiti and the United States.

2015 – 2016 HCIA Resume Book 7 2016 : Kuhns – Mayer

JOSEPH KUHNS JAMES J. LEE ROMAN LESKO [email protected] [email protected] [email protected] Finance and Private Equity Finance and Strategy Finance Georgetown University University of Pennsylvania Cornell University Washington, District of Columbia Philadelphia, Pennsylvania Ithaca, New York BA, History, 2006 MB, Molecular Biotechnology, 2008 BA, Economics, 2010 BAS, Bioengineering, 2006 THE BLACKSTONE GROUP, New York, NY DEUTSCHE BANK, New York, NY Summer Associate GENENTECH, South San Francisco, CA Summer Associate 2015 Business Development Intern 2015 Advised on distressed situations to 2015 Advised strategic alternatives on buy-and- creditor and debtor clients. Supported development of the BD strategy sell-side M&A processes for healthcare and business plan for a novel approach companies. S.A.C. CAPITAL, New York, NY for cancer immunology. Healthcare Services Analyst NAVIGANT CONSULTING, New York, NY Led the preliminary evaluation of early 2012 – 2014 Senior Consultant stage biotech companies. Covered over 100 healthcare services 2010 – 2015 companies for portfolio manager with Supported term sheet negotiations, Completed over 40 projects for life $500m in capital. CDA negotiations, and out-licensing sciences industry clients in business opportunities. Generated investment ideas through development and licensing, pipeline development, new product planning and fundamental quantitative and qualitative ACCENTURE, New York, NY commercialization, marketing, and life research including financial modeling, Consultant cycle management. management meetings, valuation analyses, 2010 – 2014 and diligence with industry experts. Formed the strategy and operations Helped clients reach investment decisions of TransCelerate, a non-profit company based on market trends, unmet needs, BARCLAYS, New York, NY focused on industry collaboration for and competitive landscapes by conducting Assistant Vice President clinical trials. primary research with key opinion leaders, 2010 – 2012 analyzing secondary resources including Analyzed Managed Care sector and Assessed the launch readiness of a scientific / medical literature and sales provided recommendations to institutional Japanese company entering the US data, and building revenue models based investors; coverage universe encompassed oncology market. on epidemiology and market dynamics. 15 stocks and roughly $150b in total Devised a framework diagnostic to Championed the development, refinement, market capitalization. measure and benchmark innovation for and growth of new quantitative research Senior analyst ranked #1 in 2012 biopharmaceutical R&D organizations. methodologies and trained junior staff on Institutional Investor Managed Care quantitative market research. SYNYGY, Philadelphia, PA sector poll; received top overall score in Associate Promoted from Consultant to Senior 2012 annual Sales & Trading survey of 2008 – 2010 Consultant in recognition of commitment Research Associates (of approximately to quality and client satisfaction. 90 Associates). Evaluated the performance and designs of sales forces across pharmaceutical business units. Led the implementation of sales incentives models for new product launches.

UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE, Philadelphia, PA Research Specialist 2006 – 2008 Research in cancer biology with published work through six peer reviewed high impact scientific journals including first-authorship.

8 2015 – 2016 HCIA Resume Book JONATHAN LICHTINGER C. ADELE MAASS ELENA MAYER [email protected] [email protected] [email protected] Marketing and Consulting Operations and Consulting Marketing and Social Enterprise Boston College Dartmouth College Mailman School of Public Health, Chestnut Hill, Massachusetts Hanover, New Hampshire Columbia University BA, Mathematics 2010 BA, Government, 2009 New York, New York MPH, 2016 REGENERON, Tarrytown, NY DELOITTE CONSULTING, Boston, MA Barnard College, Columbia University MBA Intern Summer Associate New York, New York 2015 2015 BA, Economics, 2010 Formulated the go-to-market strategy Prepared regional healthcare provider for for a Phase II cardiovascular molecule and ICD-10 go-live by creating a management PFIZER, New York, NY successfully convinced leadership to shift plan for launching an ICD-10 command Marketing MBA Summer Associate strategies from a primary care focus to an center, developing a strategy to minimize 2015 orphan disease approach, resulting in a payment denials and accounts receivable, Led concept development and execution dramatic increase in expected profitability. and conducting market research with on two new marketing tactics for a US lung payers and providers. Modeled the market potential of an antibody cancer brand: a six-section newsletter to targeting an ultra orphan indication, Identified opportunities for health systems drive sales force performance and confer- Fibrodysplasia Ossificans Progressive, and to capitalize on ICD-10 data to improve ence panels to promote biomarker testing. developed a process to expand diagnosis population health. rate uptake, increasing projected peak US AGENCY FOR sales by 20%. OKHATI, INC., Cambridge, MA INTERNATIONAL DEVELOPMENT, Pro Bono Consultant Washington, DC Developed a compelling opt-in document 2013 - 2014 Market Access Intern, Center for for a potential Sanofi partnership on a Accelerating Innovation and Impact new pipeline product, crucial for acquiring Collaborated in development and rollout 2014 necessary launch funding. of start-up nonprofit’s online interactive Nepali healthcare facilities map, Conducted Ethiopian market analysis MCKINSEY & COMPANY, Summit, NJ ask-a-doctor resource, and innovation for a new maternal health device in Pharmaceutical Research Analyst initiatives. development by Becton Dickinson (BD). 2011 – 2014 BOSTON CHILDREN’S HOSPITAL, Led 20+ stakeholder interviews in Designed innovative hospital survey and Boston, MA Addis Ababa; synthesized desk and field created new go-to-market strategies Pro Bono Summer Consultant research into final strategy for USAID allowing pharmaceutical companies to 2013 and BD. more effectively target hospitals and improve access to physicians, thereby Expedited and standardized clinical NEW YORK CITY ECONOMIC increasing revenues by 15%. research data capture by building online DEVELOPMENT CORPORATION, template for 300 most frequent New York, NY Led development of a resource allocation lab tests. Senior Project Manager tool across commercial costs and 2010 – 2013 headcount that identified over $500m in CHATHAM PARTNERS, Waltham, MA commercial efficiencies and cost Associate VP (2011 – 2014) Directed three programs to connect improvement opportunities across multiple Sr. Research Analyst (2010 – 2011) low-income NYC residents to job biopharmaceutical clients. Research Analyst (2009 – 2010) opportunities in growth sectors (i.e., healthcare, technology); responsible Projected market evolution and analyzed Managed 8-10 market research projects’ for a $1.8m budget and the work of market share potential for a $125m private design, implementation, analysis, project nine contractors. equity biopharmaceutical acquisition. teams, and client relationships concurrently. Designed and pitched initiative to create Integrated disparate projects to achieve small businesses on city-owned vacant cohesive view of client lifecycle, drivers of lots in distressed neighborhoods; led team retention, and competitive positioning. of 12 across eight departments and coordinated across six City agencies.

2015 – 2016 HCIA Resume Book 9 2016 : McGrane – Patel

GEOFF MCGRANE SRISHTI MIRCHANDANI DONNA MORDENTE [email protected] [email protected] [email protected] Venture Capital Strategy and Entrepreneurship Consulting and Operations New York University Washington University in St. Louis Cornell University New York, New York St. Louis, Missouri Ithaca, New York BA, Economics, Mathematics, 2009 BA, Economics, Healthcare Management, BS, Industrial & Labor Relations, 2010 2010 MEDPRO INVESTORS LLC, GENENTECH, South San Francisco, CA New York, NY ATHENAHEALTH, Watertown, MA MBA Intern Intern Summer Intern, Product Strategy 2015 2015 – Present 2015 Conducted stakeholder interviews across Screened biotech and pharmaceutical Analyzed competitive intelligence to the business and Global Pharma investment opportunities ranging from recommend care coordination product Procurement (GPP) to analyze value delivery preclinical to completed Phase II. positioning and marketing. throughout the research and drug Presented company summaries, analyses, Determined market entry strategy for development lifecycle. and recommendations to management a non-traditional customer base, with goal Created and implemented the 2015 GPP in strategizing meetings. of 30% annual growth. Marketing Strategy and Plan to better Created and maintained databases tracking embed Scientific Sourcing as a trusted, ACCRETIVE HEALTH, Chicago, IL deal flow and co-investor prospects. innovative, and valuable business partner. Manager, Population Health Solutions Presented project findings, marketing Contributed to due diligence performed 2013 – 2014 recommendations, and tactical execution on a cell therapy company targeting a Managed consulting services to advise cure for T1DM. activities to senior leadership and major hospital and health systems on best employees. practice financial, operational, and clinical TRIBECA ANGELS, New York, NY transitions to value-based care. Fall Intern DELOITTE CONSULTING, New York, NY 2014 Formulated financial model and business Consultant (2012 – 2014) Analyst (2010 – 2012) Prepared initial screening reports on case for new oncology population health consumer finance tech and big data product. Redesigned and implemented over 25 start-ups. Designed and implemented peer-led business processes for an estimated 50% efficiency gain in operations and potential Constructed investment memo template. continuous learning program among division associates. net savings of $3m for a diversified life sciences company. 118 CAPITAL, New York, NY Fall Intern DELOITTE CONSULTING, Chicago, IL Conducted a pharmaceutical work activity 2014 Consultant analysis to measure current-state distribution 2010 – 2013 Assessed opportunities and submitted of employee work effort and potential cost recommendation on a sustainable agricul- Created financial model to select ideal savings generated through streamlined ture company to investment committee. growth strategy for $30b insurance company service delivery. based on market, product, customer, and Probed entrepreneurs at pitch night. Facilitated the simultaneous integration channel variants. of a pharmaceutical company’s HR function S&P CAPITAL IQ LCD, New York, NY Engaged physician advisory group across across five acquisitions, with impacts to Senior Analyst II (2012 – 2014) a 3,000-physician healthcare entity to guide over 69 countries globally. Senior Analyst (2011 – 2012) electronic medical record implementation, Devised and launched a comprehensive Research Analyst (2010 – 2011) including achievement of meaningful use. project management framework and Managed US high-yield corporate bond Led energy spend management initiative supporting toolkit to track integration research product, resulting in a standalone for multinational media holdings company, activities and over $120m in M&A-related subscription-based package of news resulting in $8m - $9m annualized cost spend. and data analytics offered to market savings. participants for $22,500 per year. Developed and presented firm eminence Trained six new hires. research with Health Plan Consumer Rewrote 40-page training manual. Engagement team.

10 2015 – 2016 HCIA Resume Book LINDSEY MURRAY DILBER S. MUTLU KOMAL PATEL [email protected] [email protected] [email protected] Consulting and Private Equity Consulting and Strategy Management and Entrepreneurship Georgia Institute of Technology University of Michigan Dartmouth College Atlanta, Georgia Ann Arbor, Michigan Hanover, New Hampshire BS, Industrial Engineering, 2010 BSE, Industrial Engineering, 2004 MPH, 2012 Case Western Reserve University FORTRESS CAPTIAL FINANCE, H&M, New York, NY Cleveland, Ohio New York, NY District Controller Summer Intern BA, Political Science, Chemistry, 2009 Summer Associate 2015 2015 Analyzed key sales performance metrics MONTEFIORE HEALTH SYSTEM, Constructed financial model for a and collaborated with H&M store New York, NY transactional assessment that allowed for management to implement initiatives that Strategic Planning Intern potential 10-year cash flow of $120m. increased sales conversion at peak times 2015 up to 4% for two high profile Manhattan Measured appropriate value of portfolio Created strategic planning document for stores. company’s pipeline product assets to creation of innovation center, equipped determine possible market opportunities, Developed recommendations and action with an investing arm and incubator. peak sales scenarios, and pro forma plans to apply the most impactful solutions Assisted and analyzed opportunities in revenue and operating synergies. across all stores within the district. analytics for DSRIP funding and creation of ACCENTURE, Atlanta, GA HURON CONSULTING GROUP, regional cancer center. Consultant New York, NY ALVAREZ & MARSAL, New York, NY 2011 – 2015 Manager (2012 – 2014) Associate, Healthcare Industry Group Associate (2007 – 2012) Created strategic plan focused in data 2012 – 2015 analytics that allowed for a 2,000+ bed Managed engagements with teams of Led analysis on for-profit health system healthcare system to gain roughly 10% of up to 10 consultants per project. sale to another for-profit health system existing revenues in incentive based Implemented for hospitals $2.5m to on behalf of hedge fund, resulting in sale rewards. $15m annual cost savings through of HMA to Community Health System. Designed clinical interface functionality productivity improvement, process Created and implemented quality by leading over 80 technical build sessions redesign, organizational restructuring, improvement system for 1,000 bed hospital that created over 200 customized and reduction in contract labor and at risk of Joint Commission and HSS interfaces for electronic ordering that premium pay. regulation failure, resulting in passing replaced 80% of the existing paper Established system-wide operational certifications. ordering system. performance targets and monitoring tools Completed cash flow analysis and asset to drive economic growth in multi-hospital sale opportunity for community hospital systems and academic medical centers. with bond violation, resulting $40m cash Implemented vacancy management policy flow infusion. and procedures to better manage new or replacement positions. HURON CONSULTING GROUP, New York, NY HARBOUR CONSULTING GROUP, Analyst Troy, MI 2010 – 2011 Manager (2006 – 2007) Performed marketing and drug pipeline Analyst (2005 – 2006) development analysis for improved Managed North American clients of the efficiencies for top 10 pharmaceutical firm. Harbour Report, the most comprehensive Performed analysis and consolidated CRO evaluation of the automotive industry’s functions for academic medical center. performance internationally.

2015 – 2016 HCIA Resume Book 11 2016 : Qiu – Shen

SYLVIA QIU TANYA RANA JESSICA H. ROE [email protected] [email protected] [email protected] Private Equity and Venture Capital Consulting and Strategy Strategy and Marketing Icahn School of Medicine at Mount Sinai Georgetown University Harvard University New York, New York Washington, District of Columbia Cambridge, Massachusetts MD, 2016 BS, Health Studies, 2009 BA, Economics, French, 2010 Princeton University Princeton, New Jersey ZOCDOC, New York, NY REGENERON, Tarrytown, NY AB, Molecular Biology, 2008 Healthcare Strategy Intern New Products Intern 2015 2015 CERBERUS CAPITAL MANAGEMENT, Served as a business operations represen- Identified new market opportunities in New York, NY tative on multidisciplinary product team. ophthalmology for products in preclinical Private Equity Summer Associate (2015) Designed dynamic report to regularly and clinical stages of development. Private Equity Summer Analyst (2014) monitor, measure, and communicate SIMON-KUCHER & PARTNERS, progress on key performance indicators. Evaluated control investments in health- Cambridge, MA, San Francisco, CA care, telecom, and consumer sectors MERCER, Health and Benefits, New York, NY Life Sciences Consultant through financial, market, strategic, and 2010 – 2013 operational due diligence and analysis. Associate (2013 – 2014) Senior Analyst (2011 – 2013) Managed a five member team for a launch Integrated findings for presentation to Analyst (2010 – 2011) pricing and reimbursement strategy investment committee and composed term Redesigned healthcare benefits strategies project involving a competitive landscape sheets detailing investment structure. and programs for various Fortune 500 assessment, value messaging, and profit Liaised with leadership of healthcare companies. optimization modeling. portfolio companies to monitor financials, Projected costs and liabilities for clients Built a competitive reaction simulator in assess operating performance, and with benefits budgets ranging from Visual Basic for the manufacturer of an identify potential acquisitions. $50 – $200m. Often negotiated fees and injectable biologic drug in anticipation of the entry of a competing biosimilar. CORIDEA, New York, NY premiums with large healthcare insurance Summer Intern companies. Optimized the contracting, bundling, and 2013 Developed custom employee wellness pricing of machines, services, and disposables for the launch of a novel End Assessed market opportunity of novel programs, resulting in increased employee Stage Renal Disease treatment system. intervention to slow progression of chronic participation and positive health outcomes. kidney disease; analyzed clinical trial Recruited intern and entry-level candidates Designed and fielded quantitative and design, cost-effectiveness, and potential as well as supervised summer intern qualitative surveys, ran Excel and SPSS competitors/acquirers. program. analyses to evaluate opportunity for a new pain medication. CITI, New York, NY Earned promotions from Analyst to Chaired development of three annual Analyst, Interest Rate Derivatives Associate within fastest possible trajectory. “Life Sciences Strategy and Marketing 2008 – 2010 FORTIS LA FEMME, New Delhi, India Forums” achieving record turnouts and lead Advised corporate clients on use of Summer Intern generation; built multiple winning project interest rate derivatives to meet financing 2008 proposals for new project sales. and hedging needs. Investigated and suggested techniques to Structured, priced, and executed increase admission and discharge efficiency derivatives including rate locks, interest rates. swaps, and options. Crafted and analyzed inaugural employee survey.

12 2015 – 2016 HCIA Resume Book ERIC SCHNIPPER STEPHANIE SCHREIBER SHIJIA (GRACE) SHEN [email protected] [email protected] [email protected] Management and Private Equity Private Equity Finance and Management Columbia University Northwestern University Melbourne University New York, New York Evanston, Illinois Melbourne, Australia MPH, Health Policy and Management, 1996 BA, Economics, 2010 MS, International Tax, 2010 BS, Commerce, 2004 New York Medical College Valhalla, New York HEALTH ENTERPRISE PARTNERS, MD, 1994 New York, NY STARWOOD HOTELS & RESORTS MBA Associate Intern WORLDWIDE, Stamford, CT University of Pennsylvania 2014 – Present MBA Intern, Global Brand Finance Philadelphia, Pennsylvania Identify and evaluate potential investment Summer 2015 BA, American History, 1990 opportunities, conduct financial, market, Interacted with teams across disciplines and competitive due diligence, and within organization; identified key drivers of BLUE DOT HOLDINGS, LLC/ prepare indications of interest and internal marketing spend and determined most NRAD MEDICAL ASSOCIATES, investment memoranda. appropriate metrics; developed a standard Garden City, NY Work closely with senior management of way to track and evaluate the effectiveness Owner/Partner of brand marketing across 10 brands and 2003 – Present portfolio companies. Experience includes long-term strategic planning, development four divisions. Led largest physician-owned medical of go-to-market initiatives, and evaluation imaging company in the Northeast to 42% DELOITTE TOUCHE TOHMATSU, of adjacent market opportunities. increase in revenue growth and successful Shanghai and Beijing, China merger with NYU Langone Medical Center OLIVER WYMAN, New York, NY Tax Manager (2012 – 2014) in 2015. Engagement Manager (2014) Tax Associate (2006 – 2009) Frequent television commentator on Associate (2013 – 2014) Specialized in cross-border M&A, international healthcare economics and politics on Senior Consultant (2012 – 2013) tax planning, pre-IPO structuring, and tax CNBC and Fox Business since 2009. Consultant (2010 – 2011) risk management. Director of Association for Quality Imaging, Designed and implemented a care model Advised Fortune 500 US company on leading outpatient medical imaging for high-risk Medicare patients for a acquisitions and operations in China. lobbying and advocacy group since 2009. $21b health plan. Developed tax management policy and Developed a $1.9b health services procedures for $15b tech/real estate/finance INADVANCE HEALTH IMAGING, opportunity for a $20b supermarket chain conglomerate to optimize tax compliance New York, NY including internal employee, employer, and risk mitigation. Founder/CEO/Owner and consumer market- facing offerings. 2001 – 2003 Reviewed and prepared tax returns and Transformed a multi-specialty physician supporting documentation for five plus Founded start-up medical imaging practice, group into a value-based population health clients in CPG/healthcare industries; secured angel investors, and managed all manager. coordinated distribution of deliverables to aspects of business. Valued a $1.8b Phase II rheumatoid clients and returns filing under strict MEMORIAL SLOAN-KETTERING CANCER arthritis asset for a global pharmaceutical deadlines. CENTER, New York, NY company; identified alternative develop- Assisted 10+ international clients on tax 2000 – 2001 ment strategies to generate additional issues relating to China operations, Fellowship in Body Imaging. value. including permanent establishment and . foreign exchange remittance; conducted tax COLUMBIA UNIVERSITY, New York, NY compliance review and due diligence. 1996 – 2000 Residency in Diagnostic Radiology.

2015 – 2016 HCIA Resume Book 13 2016 : Sutton – Yang

NATALIE SUTTON COLIN THIMONS HARSH TIWARI [email protected] [email protected] [email protected] Operations and Strategy Consulting and Venture Capital Marketing and Strategy University of North Carolina Boston University Cornell University Chapel Hill, North Carolina Boston, Massachusetts Ithaca, New York BS, Business Administration, 2011 BA, International Relations, 2005 MEng, Computer Science, 2006 American University UCLA HEALTH, Los Angeles, CA GLG, New York, NY Dubai, United Arab Emirates Administrative Intern, Operations Manager, Business Development – BS, Computer Engineering, 2005 2015 Life Sciences 2014 Redesigned infusion center scheduling ALLERGAN PLC, Jersey City, NJ processes to reduce overbooking and Advised Fortune 500 life science clients Insights and Analytics, BU Lead increase patient and staff safety and on strategic decision making around central 2014 – Present satisfaction. market and policy trends. Supported Lead the strategy, insights, and analytics corporate venture capital, business devel- Formulated a population health business team for the $2.5b Internal Medicine opment, commercial, and strategy business plan to shorten mothers’ post-birth length- franchise. of-stay and generate savings of $0.5m. units through the identification, initiation, and execution of projects to address Manage $3m annual market research ING U.S., New York, NY commercial priorities. budget and secondary data contracts for the franchise. Analyst, Strategy, Corporate Development, Oversaw business development team and Investor Relations within diverse pharmaceutical, biotechnology, Designed DTC campaign for three brands 2012 – 2014 and medical device corporations throughout projected to garner $1.5b sales in 2015. Crafted the equity story and facilitated North America, Europe, and Asia. NOVARTIS, East Hanover, NJ ING U.S.’s $1.5b IPO as the lead analyst on Insights and Analytics, Team Lead the roadshow; the stock appreciated HOYA VISION CARE, New York, NY 2013 – 2014 70% in the first year of trading. Brand Manager 2010 – 2014 Co-designed end-of-life strategy for a Drafted materials for the first public $6b brand and achieved $175m incremental earnings release. Led and influenced decision making cross- functionally, particularly as it pertained to sales. Coordinated content and logistics for the developing insights-based marketing Assessed commercialization strategy for first- and second-ever Executive strategies to improve consumer outcomes new formulation and informed clinical Committee Strategy Conferences and for ophthalmic lens product mix. funding decision; product to garner $400m oversaw resulting enterprise-wide Responsible for channel and tactic planning in sales. strategic initiatives. and development, implementation, and Constructed analyses and synthesized measurement for portfolio. Strong focus on ZS ASSOCIATES, New York, NY results into an executable deal structure large retail contract negotiations, pricing Consultant (2011 – 2013) for the $722m sale of private equity limited strategy, and product launches to support Associate Consultant (2009 – 2011) partnership investments. Hoya’s global laboratory network. Associate (2006 – 2008) Devised and implemented a plan that Co-developed and led implementation of improved team performance by 40% in ABBOTT MEDICAL OPTICS, New York, NY the launch plan for two brands forecasted one year. Territory Sales Representative to garner $1b in peak sales. 2006 – 2010 Partnered with executive leadership to MORGAN STANLEY, New York, NY Led as consultative sales representative start an international office; built the Investment Banking Analyst for AMO’s cataract and refractive product foundation to make this office ZS’s most 2011 – 2012 portfolio; promoted portfolio to ophthalmol- profitable outsourcing office. Prepared roadshow materials and managed ogists within surgical centers and hospitals; Re-designed and operationalized over four co-manager teams to position excelled in product launches and achieved 10 business intelligence systems to reduce Michael Kors for a successful $1.1b IPO. top performer recognition. client’s process management costs by 50%.

14 2015 – 2016 HCIA Resume Book MARK VILLANUEVA ANDREA WANG ZHI YANG [email protected] [email protected] [email protected] Strategy and Management Marketing and Strategy Strategy and Consulting Tufts University University of California, Berkeley Beijing Jiaotong University Medford, Massachusetts Berkeley, California Beijing, China BA, Economics, Drama, 2008 BA, Public Health, Economics, 2008 BE, Computer Science, 2005

BAYER AG, Whippany, NJ GENENTECH, South San Francisco, CA PFIZER, Beijing, China Brand Management Intern Summer Intern, Respiratory Marketing Senior Manager, Strategy & Operations 2015 2015 2010 – 2014 Analyzed American Heart Month Developed an unbranded P2P asthma Led Sales Reorganization Project, including promotional spending, recommending new disease education module for an upcoming sales force sizing, product lines grouping, marketing mix with 28% cost savings. drug launch. Succeeded in obtaining legal territories assignment, and coordination Investigated brand and category trends to and regulatory approval for the module, across business units. explain sales decline and risk to revenue to be featured at over 14 conferences. Negotiated China Region’s annual budget projections. Managed external agency for KOL with Pfizer’s headquarters, reallocating Advisory Board setup and disease budget and reducing costs by $20m. WEILL CORNELL MEDICAL COLLEGE, education module development. Initiated Market Segmentation Program New York, NY Partnered with market research, to differentiate marketing strategies and Research Assistant competitive intelligence, managed care, revenue targets in 6,000+ local hospitals. 2013 – 2014 and medical affairs to extract key Coordinated department initiated studies insights. IMS HEALTH, Beijing, China and clinically investigated on Phase III Senior Business Analyst drug and device studies. WILLIAMS SONOMA, INC., 2006 – 2010 Created visuals and edited papers and San Francisco, CA Designed expansion strategy for the posters for academic publication and Strategic Planner largest over-the-counter drug company presentation. 2012 – 2014 by building market sizing model and priori- Created and managed a promotions tizing products, channels, and geographies. THE PRINCETON REVIEW, Boston, MA planning tool, driving improved forecasting Conducted in-depth research on Chinese Master Tutor of 15% and $200m in annual promotion pharmaceutical industry’s market dynamics, 2008 – 2011 sales. value chain, competitive landscape, Coached students on test preparation Presented monthly brand-level sales business models, and regulations. leading to gains as high as 200 points on forecasts of ~$40m to the president. the GMAT and 600 points on the SAT. Identified investment opportunities for first-tier private equity fund in therapeutic BARE ESCENTUALS, INC., Overhauled recruiting, hiring, and training areas with 60% higher growth potential San Francisco, CA processes and facilitated hiring of 112 than average. trainees. International Purchasing Specialist 2011 – 2012 Oversaw operations team in China to ensure appropriate factory production levels, reducing scrap percentages by 3%.

MERCER LLC, San Francisco, CA Senior Analyst, Health & Benefits 2008 – 2010 Realized millions of dollars in cost savings by matching clients with best-in-class insurance carriers.

2015 – 2016 HCIA Resume Book 15 2016 : Zeyneloglu 2017 : Ault – Castagnola

NEJAT ZEYNELOGLU, M.D. LISA AULT CARLY BIGI [email protected] [email protected] [email protected] Management and Operations Consulting and Strategy Strategy and Marketing Egean University School of Medicine University of Southern California Vanderbilt University Izmir, Turkey Los Angeles, California Nashville, Tennessee MD, 2000 BS, Business Administration, 2010 BS, Human and Organizational Development, Corporate Strategy, 2012 BROOKHAVEN MEMORIAL HOSPITAL, FUJIFILM SONOSITE, Bothell, WA Brookhaven, NY Marketing Manager DELOITTE CONSULTING, Chicago, IL Vice President, Chief Quality Medical Officer 2013 – 2015 Senior Consultant (2015) 2015 – Present Analyzed potential of Canadian point- Consultant (2014 – 2015) Oversee cost reduction and efficiency of-care ultrasound market to develop a Analyst (2012 – 2014) initiatives in the hospital. marketing strategy that was presented to Transformed structures of 87 hospitals Drive CMS value-based purchasing Canadian sales team and leadership. in $14b healthcare system; collaborated & DSRIP initiatives. Spearheaded development of a customer with executive leadership team to identify education web portal. consolidation opportunities that yielded Responsible for day-to-day hospital $100m in cost savings. operations. Led marketing activities for Enterprise market including development of marketing Managed redesign of global IT operating NEWYORK-PRESBYTERIAN HOSPITAL/ campaign content and support for strategic model of $6.5b pharmaceutical company to NEW YORK HOSPITAL QUEENS, relationships with Health Management support 20% growth; partnered with eight Flushing, NY Academy, National Patient Safety VPs to implement changes. Division Chief of Hospital Medicine Foundation, and CODE BLACK movie Advised 30 clinical Project Managers on 2010 – 2015 production team. strategy to manage clinical, operational, Managed two separate 24/7 service lines Collaborated with cross-functional team and talent-related changes during merger with particular focus on patient flow. to launch the Frontier Program, a global of a $2b regional hospital system; realized Led CMS core measures related pricing program. $160m in savings. performance improvement initiatives. Led creation of enterprise-wide communi- Marketing Specialist cations strategy for $550m electronic Focused on in-hospital cost reduction 2010 – 2013 and efficiency. health record system implementation and Conducted an analysis of Interventional led cross-functional team to implement Cardiology and Peripheral IV point-of-care METROPOLITAN HOSPITAL/ in $3b hospital system. ultrasound markets that culminated in NEW YORK MEDICAL COLLEGE, presenting findings to CEO. Co-authored week-long business case New York, NY about a global pharmaceutical company; Associate Residency Program Director Created marketing collateral that has led 11-person team to deliver national 2008 – 2010 continued to be utilized by global team case-based training to 350+ new hires; Served as a core faculty with an emphasis including a 32-page evidence-based booklet increased effectiveness of training by 60%. on medical education. highlighting quality, safety, and cost benefits of ultrasound utilization for 12 invasive procedures. Selected as a presenter for Global Strategy Session during 2013 international sales meeting for 450 attendees.

16 2015 – 2016 HCIA Resume Book ZACHARY BOGNER BROOKE A. BONET GUIDO CASTAGNOLA, MD [email protected] [email protected] [email protected] Marketing and Management Strategy and Operations Management and Consulting The George Washington University Tufts University Instituto Universitario Hospital Italiano Washington, District of Columbia Medford, Massachusetts Buenos Aires, Argentina BBA, Marketing, 2011 BA, English and Spanish Language and Psychiatrist, 2008 Literature, 2009 Universidad Austral IBM, Washington, DC Buenos Aires, Argentina Senior Consultant (2013 – 2015) IRONWOOD PHARMACEUTICALS, MD, 2004 Consultant (2011 – 2013) Cambridge, MA Program Manager Managed teams through the software PRIVATE PRACTICE, Buenos Aires, Argentina 2012 – 2015 development lifecycle delivering projects Owner and Principal Physician both on time and on budget. Managed process to quantify unmet need 2006 – 2015 in six disease indications to expand and Evaluated clinical trial datasets for Managed entire practice: negotiated rates prioritize acquisition targets. accuracy against clinical trial standards— with HMO, set private rates, acquired office SDTM and SEND. Identified inconsistencies Analyzed financial, target prescriber, space, advertising, hiring, and compliance between the clinical trial data and the pipeline, and IP data for 46 potential with legal requirements for health records. standards. Created recommendations for target assets. Distinguished for having achieved, among improving adherence to the standards. Designed and implemented in-licensing 2,000+ psychotherapists, quickest time Directed a division-wide review of different process that reduced time for go/no-go to recovery/discharge and third lowest clinical trial analysis tools. Identified decisions by 10%. recidivism rate. strengths and weaknesses of each tool, Led nine-person intelligence team to INECO, Buenos Aires, Argentina researched industry best practices, and assess competitor cost structure, saving Neuropsychiatry Fellowship: Attending created a strategic plan for the improved $5m in manufacturing costs. use of clinical trial analysis tools. Neuropsychiatrist and Assistant to CEO Created US launch Sales Training Plan Medical Director Organized and presented during training for 165 field employees, successfully 2008 – 2009 seminars to educate onboarding consul- implementing plan in one week. tants on clinical trial standards and analysis. Co-led 14 people in cross-functional team Implemented Sunshine Act government implementing research protocol for study Wrote SAS and SQL programs to support spend policies company-wide with of frontotemporal dementia. Assigned tasks, clients in gleaning actionable information Compliance and rectified 2,000 errors. supervised work, and ensured adherence from large datasets. Liaised with US and European teams to to protocol. 35+ original papers published Analyzed key metrics and trends, creating submit launch dossiers in Switzerland, based on results of study. dashboards for an IBM partner. The dash- Ireland, Spain, and Germany. boards allowed the partner to gain a quick HOSPITAL ITALIANO, understanding of the performance of the GENZYME CORPORATION, Buenos Aires, Argentina project. Cambridge, MA Resident Physician Senior Project Coordinator 2005 – 2008 2009 – 2012 Managed four psychiatric ward facilities: Chaired 10 coordinators across business 42-bed in-patient care department, units, delegating execution of dynamic outpatient psychiatric care, emergency ad hoc projects. consultation, and cross-hospital psychiatric emergencies for a 500-bed general hospital. Pioneered four product Program Management dashboards for executive Handled triage and intake for emergency management to prioritize resource service; regularly made life-and-death allocation. decisions on tense and uncertain emergency scenarios, resolving differences of opinions. Analyzed 51 Sales Time Study Surveys, formulating insights used in 2010 sales re-realignment.

2015 – 2016 HCIA Resume Book 17 2017 : Chen – Dayal

CECE CHEN BRANDON CHEONG JAMES CHEUNG [email protected] [email protected] [email protected] Consulting and Entrepreneurship Private Equity and Corporate Development Private Equity and Management Northwestern University University of Pennsylvania MIT Sloan School of Management Evanston, Illinois Philadelphia, Pennsylvania Cambridge, Massachusetts MS, Biomedical Engineering, 2011 BS, Finance, 2010 Master of Finance, 2011 BS, Biomedical Engineering, 2010 University of California, San Diego MERCATOR FUND, SYCALE ADVISORS, La Jolla, California ACCENTURE, New York, NY New York, NY BS, Bioengineering, 2010 Business & Systems Integration Consultant Summer Investment Analyst (2014 – 2015) 2015 PERMIRA, New York, NY Analyst (2011 – 2014) Analyzed spinoffs and standalone Investment Professional Managed offshore testing team as companies across industries and made 2013 – 2015 Test Lead and drove the completion of investment recommendations to the Evaluated investment opportunities in the the functional testing phase of a financial portfolio manager. healthcare, consumer, and industrial space reporting transformation project for through detailed analysis of financial, a global Fortune 500 biotech company. CAIN BROTHERS, New York, NY Investment Banking Associate, Healthcare industry, and competitive trends. Built training materials as Change M&A (2013 – 2015) Constructed complex operating forecast Management Lead and organized training Investment Banking Analyst, Healthcare models to assess valuation and financing sessions for global client sites to adopt M&A (2010 – 2013) structures for investment and exit strategies. a new financial reporting tool. Executed numerous M&A transactions Engaged with senior management and Mapped future state product quality for healthcare services companies. industry advisors to formulate investment business processes for a $5m Oracle-based strategy and recommendation for enterprise resource planning (ERP) Worked closely with client management investment committee. implementation assessment for a global teams on sell-side M&A transactions to draft investment memorandums, prepare Fortune 500 biotech company. BANK OF AMERICA MERRILL LYNCH, investor presentations, and facilitate New York, NY Analyzed the standardization of drug due diligence processes. substance, drug product, and finished Investment Banking Analyst, Global goods release processes across global Built comprehensive financial models Healthcare manufacturing sites for a global Fortune and valued companies using a variety of 2011 – 2013 techniques, including public market 500 biotech company. Executed transactions for mergers & comparables, precedent transactions, acquisitions, initial public offerings, leverage Identified Healthcare Reform impacts discounted cash flow, leveraged buyout, buyouts, and financings. to sales, actuarial, and benefits areas and and merger analysis. mapped current state and future state Led all facets of the deal process including processes for a regional non-profit payer. valuation, engagement materials, financial Assessed data setup for an out-of-pocket and operational due diligence, and cost estimator tool that allows patients interaction with senior management across to shop and compare costs for medical the pharmaceutical, biotechnology, medical procedures online. technology, and services sector. Analyzed potential new channels for a member cost savings marketing campaign at a regional payer.

18 2015 – 2016 HCIA Resume Book KEVIN COLLINS ELIZABETH COLONNA GAURAV DAYAL [email protected] [email protected] [email protected] Private Equity and Management Strategy and Operations Finance and Private Equity Yale University University of Virginia Indian Institute of Management New Haven, Connecticut Charlottesville, Virginia Ahmedabad, India BA, Economics, 2009 BA, Economics, Spanish, 2010 Post Graduate Diploma, Management, 2008 Indian Institute of Technology GOLDMAN SACHS, New York, NY FTI CONSULTING, New York, NY Kanpur, India Associate Senior Consultant (2013 – 2015) BTE, Electrical Engineering, 2005 2012 – 2015 Consultant (2010 – 2013) Private equity associate in the special Analyzed 100m records of transactional NBK CAPITAL (investment banking arm situations group, focusing on healthcare data to quantify potential exposure for of NATIONAL BANK OF KUWAIT), Kuwait and business services companies. retail pharmacy client involved in litigation Assistant Vice President Completed investments in Forefront with alleged damages of over $150m. 2012 – 2015 Dermatology and Resolute Anesthesia Created 12+ SQL models based on state Advised on 10+ buy-side, sell-side, and and Pain Solutions. Medicaid generic drug pricing rules, public offering transactions across sectors, Assisted portfolio company Forefront which influenced litigation strategy for including healthcare. a senior managing director serving as Dermatology as Director of Corporate Prepared board presentations, investment expert witness. Strategy. memos, offering prospectuses, and road- Developed cross-functional client show presentations. FIDELITY MANAGEMENT AND RESEARCH, relationships with departments including Led and mentored a team of analysts/ Merrimack, NH Revenue Projections, Data Remediation, associates on various transactions. Research Associate Legal, and Technical Engineering, helping 2009 – 2012 to streamline communication and Designed and delivered peer-training Performed fundamental credit analysis reconcile internal discrepancies. courses on building efficient pitch books to generate investment recommendations and valuation. Overhauled complex claims data system for fixed income securities issued by for large managed care organization, which insurance, healthcare, and pharmaceutical ERNST & YOUNG, Kuwait processes millions of claims per year to companies. Executive CMS for Medicare Advantage. 2009 – 2012 Led team of three consultants by Advised on valuations, buy-side, sell-side, developing their technical skills, reviewing and restructuring transactions across their work product, and drafting work sectors. plans. Led and mentored a team of analysts. Saved client millions of dollars by creating a model that became an integral HSBC, Mumbai, India component of the company’s internal Manager, Special Projects process to accurately quantify reserves. 2008 – 2009 Generated accounting analyses of payer’s Managed the integration of IL&FS claims fund, which was the focus of InvestSmart, a retail brokerage firm litigation with alleged damages of over acquired by HSBC India in 2008. $3m; results were presented in managing Compiled an integration plan, and director’s expert report and deposition. coordinated the integration process with 10+ sub-teams. Co-authored a post-acquisition due diligence report.

2015 – 2016 HCIA Resume Book 19 2017 : Dukes – Fedejko

DANIELA DUKES CHRISTIAN DUNNE LEV ELDEMIR [email protected] [email protected] [email protected] Finance and Management Management and Marketing Consulting Pontificia Universidad Católica de Chile Skidmore College University of California, Berkeley Santiago, Chile Saratoga Springs, New York Berkeley, California Professional Degree, Commercial BS, Business, Art, 2007 BS, Business Administration, 2010 Engineering, 2012 BS, Business Administration, 2011 ABB OPTICAL GROUP, Chicago, IL FRONTIER HEALTHCARE, New York, NY Account Manager Operations Associate LATAM AIRLINES GROUP S.A., 2014 – 2015 2013 – 2015 Santiago, Chile Managed relationships with 27 vendor Directed a cross-functional operations Manager, Non-Flight Miles Redemption partners to ensure aggressive sales growth; team, comprised of five senior leaders, in 2014 – 2015 became distributor of choice for 22 of 27 the development of new ambulatory Determined and implemented strategy vendors within six months and increased surgery centers. of non-flight miles redemption program, sales by 28% versus the national average Served as the Practice Administrator used by over 7m clients. of 10%. of Frontier’s first gynecology surgery Managed commercial relationship with Collaborated with teams in finance, center for six months, overseeing over over 20 partners. Led multidisciplinary operations, and marketing to test a new 40 personnel and managing operational team. customer program that was later workflow, facility maintenance, billing implemented throughout the country. operations, and clinical compliance. Senior Analyst, Financial Alliances Benchmarked over 40 operational and 2013 – 2014 BIOMERS LTD, Chicago, IL financial metrics across 12 surgery centers Worked with Santander Bank to increase Key Opinion Leader & Account Manager to identify inefficiencies and cost-saving billings in co-branded credit cards and 2011 – 2013 opportunities. improve client’s loyalty by creating and Established the North American market implementing innovative campaigns. for an orthodontic start-up company by CITIGROUP, INC., New York, NY Assisted LATAM’s VP of Customers and developing and executing a marketing Capital Markets Analyst participated in the negotiation of a new strategy that led to acquisition discussions 2011 – 2013 contract with Santander Bank. with major orthodontic companies. Provided fixed income financing solutions Analyst, Financial Alliances Recruited and managed the company’s to clients through the use of unsecured, 2012 – 2013 key opinion leaders (doctors) to secured, and hybrid debt securities. Developed day-to-day work strategy with create clinical studies that established Managed the fixed income transaction Santander Bank. competitive market claims. process for clients, from pre-announcement marketing to final pricing; interfaced Co-managed the release of a new credit BAUSCH + LOMB, Chicago, IL directly with clients to brainstorm and card. Conducted comprehensive analysis Territory Manager (2010 – 2011) implement deal execution best practices. and research of the industry and alliance’s Associate (2009) competitors. Partnered with the national sales team Composed a daily distribution sent to over to develop the #1 territory (based on 1,000+ clients and senior internal bankers MCKINSEY & COMPANY, Santiago, Chile discussing industry developments, Business Analyst overall sales, profits, and growth) in the country for a large national retailer. Treasury and equity markets, and recent 2012 investment grade debt issuance. Participated in a churn reduction project Advised the marketing team on creation for a telecommunications company. of new sales material to ensure successful Implemented incentives pilot program. use by the salesforce with customers.

20 2015 – 2016 HCIA Resume Book AMANDA EVANS DAVID FARKAS PAWEL FEDEJKO [email protected] [email protected] [email protected] Finance and Strategy Corporate Development and Finance Strategy and Operations Lehigh University University of Rochester London School of Economics and Political Bethlehem, Pennsylvania Rochester, New York Science BS, Finance, Marketing, 2012 MS, Chemistry, 2010 London, United Kingdom BS, Chemistry, 2010 MSc, Management Strategy, 2011 CIT GROUP, INC., New York, NY Warsaw School of Economics Associate (2015) MEDIMMUNE, Gaithersburg, MD Warsaw, Poland Analyst (2012 – 2015) Associate Scientist (2012 – 2015) BA, Quantitative Methods in Economics, Led underwriting for multiple deal struc- R&D Associate (2011 – 2012) 2009 tures, including mergers and acquisitions, Led and worked on cross-functional clinical asset based lending, cash flow lending, drug development teams, contributing to PWC STRATEGY& (formerly BOOZ & project finance, and reserve based lending; four new INDs, two new Phase I, and two COMPANY), London, United Kingdom assisted in growing the oil and gas new Phase II clinical trials. Associate/Manager (2015) portfolio from $75m to $300m+. Built new antibody-drug conjugate Senior Consultant (2014 – 2015) Closed a $20m transaction in a new invest- manufacturing strategies and international Consultant (2012 – 2014) ment space, liquefied natural gas, resulting supply chains; achieved two $15m+ Conducted global tender risk assessment in additional new business of $50m and Phase I investment decisions. of transplant anti-rejection drugs for over $300k in fees. Performed competitive intelligence, multinational pharma. Conducted industry research, company business plan writing, and metric develop- Developed product strategy for rare valuations, risk assessment, and downside ment to support early stage partnering disease drug while acting as job manager; case sensitivities to evaluate over 20 efforts. achieved revenue upside of 10%. potential transactions, leading to invest- Supported design of new organizational ments of over $400m. ADARZA BIOSYSTEMS, Rochester, NY Research Associate structures across 15+ European markets for Managed 10+ portfolio accounts, including 2011 multinational pharmaceutical company. guiding accounts through downturns in Led team of two and developed long-term industry cycles and bankruptcy. Developed chemistry and mathematical models to support novel diagnostics manufacturing strategy for diagnostics Interviewed and recruited 10 candidates technology. Designed experiments for device start-up (acquired by multinational for full-time positions; planned and two additional laboratory employees. pharma company) by evaluating its in-house executed week-long training program for capabilities and identifying potential out- familiarizing new hires with management UNIVERSITY OF ROCHESTER, sourcing partners. expectations, goals, and corporate culture. Rochester, NY Created market access strategy for cancer Laboratory Technician screening device across several global 2010 – 2011 markets. Started up new HIV genomics wet-lab, Reprioritized over $70m of annual product sequencing patient derived samples to development spend for $15b consumer support NIH grant. goods company. Negotiated facilities sharing agreement, acquired capital equipment, and generated new experimental protocols.

2015 – 2016 HCIA Resume Book 21 2017 : Garvin – Kaplan

EMILY GARVIN RACHEL J. HAN CAROLYN HEISLER [email protected] [email protected] [email protected] Consulting and Technology Consulting and Management Management and Operations Dartmouth College Chung-Ang University Boston College Hanover, New Hampshire Seoul, South Korea Chestnut Hill, Massachusetts BA, Spanish, 2011 BA, Business Administration, 2012 BA, Economics, International Studies, 2009

THE ADVISORY BOARD COMPANY, HEALTHCARE HAN, Seoul, South Korea DELOITTE CONSULTING, New York, NY Washington, DC Manager Senior Consultant (2014 – Present) Healthcare Consultant (2012 – 2015) 2013 – 2014 Consultant (2012 – 2014) Coordinator (2011 – 2012) Developed business plans for medium Conducted annual healthcare cost projec- Led the implementation of clinical business sized hospitals and healthcare centers. tions, marketplace evaluations, claims intelligence technology at a seven- Organized logistics and contents for an analysis, and data management for large hospital system in Denver, CO, coaching educational course on Chinese healthcare client’s healthcare benefit program. staff on the use of data to impact readmis- market. Managed client’s $480m healthcare sion rates, length of stay, and other out- program to annual target and presented comes; led to facility-level improvements in Provided educational sessions for hospital management trainees, achieving a 92% program recommendations to senior joint replacement length of stay and heart management. failure readmissions. satisfaction rate. Developed strategy and approach for over Directed end-user technology training KOMEA, Seoul, South Korea 40 focus groups nationally; identified and adoption strategy for the seven Assistant Manager employee concerns with the current hospitals in Denver, including educating 2013 – 2014 healthcare program and recommended over 200 physicians about using data to Led market research on China and actions aligned with the client’s five-year improve performance on publicly developed overseas expansion strategies, strategy. reported measures. including marketing partnership with local Initiated a data and analytics strategy to clinics and utilization of venture capital, SYNAMED LLC, New York, NY facilitate superior performance on in cooperation with other government- Project Manager (2010 – 2011) an innovative, patient-centered unit of affiliated organizations. Project Coordinator (2009 – 2010) a hospital in Denver; led to $600k+ Analyzed Electronic Health Record (EHR) in savings, improved quality outcomes, SEOUL ST.MARY’S HOSPITAL, system capabilities to identify and manage and citations in case studies. Seoul, South Korea implementation of changes required to Associate Analyzed data trends for a hospital in CA, comply with federal EHR certification. 2012 – 2013 and guided CFO and VP of Quality on Demonstrated EHR system features approach for training physicians on how Conducted and partnered with cross- to federal inspectors from Office of the to improve stewardship of resources, divisional task force teams, as well as National Coordinator, resulting in award resulting in upwards of $717k in savings surgeons, to allocate $5m budget dedicated of certification and a distinct marketing and enhanced physician experience. to construction of new operating facilities; advantage for the company. presented findings to CEO. Restructured processes governing donations; streamlined donation channels and implemented updated system to inform donors of use of their donations.

22 2015 – 2016 HCIA Resume Book FRANCES HOU MISHA IPATOV HILLARY KAPLAN [email protected] [email protected] [email protected] Strategy and Entrepreneurship Entrepreneurship and Management Strategy and Venture Capital Shanghai Jiao Tong University University of Geneva University of Pennsylvania Shanghai, China Geneva, Switzerland Philadelphia, Pennsylvania BA, Material Engineering, 2012 MA, International Trading, 2010 BA, Politics, Philosophy, & Economics, 2009 BS, Business Administration, 2008 MONITOR GROUP / MONITOR DELOITTE THE DEDHAM GROUP, New York, NY CONSULTING, Shanghai, China CHS EUROPE, Geneva, Switzerland Senior Analyst (2014 – 2015) Consultant Internal Project Manager Analyst (2013 – 2014) 2012 – 2015 2015 Managed strategy consulting projects with a Developed robust growth strategy for Evaluated business model in Russia and focus on oncology market access for large global pharmaceutical and medical device prepared a five-year scenario analysis, pharmaceutical clients. leaders; evaluated and facilitated multi- resulting in radical shift of company’s Led primary research programs, performed million dollar acquisition deal; restructured strategic focus and in office headcount data analytics, and developed strategic organization of 300+ people. reduction from 40 to seven people. recommendations. Promoted by Partner to serve as Trader Analyzed the risk of healthcare providers Project Leader ahead of peers; strategized 2012 – 2015 switching to a competitive drug and created customer data generation plan and Led EMEA corn profit center delivering a financial model to assess switching impact. directly presented to Asian Head. $3.3m of gross profit during last six months Segmented health insurers to design a Designed first-of-its-kind mobile of trading - the best performance among targeted sequencing strategy for prostate application to offer integrated pharmacy all units for the same period. cancer therapies. services in China. Managed and mitigated contractual and Developed a portfolio-level regional access Created innovative pricing model logistical exposure from Russian-Ukrainian sales force strategy. and market entry strategy to launch crisis. Directed negotiation strategy with new drugs. suppliers, assessed daily default exposure, Assessed biomarker utilization to optimize and oversaw arbitration for legal cases. market access for a therapy and its Launched pioneering primary care companion diagnostic. systems in medical zone. Regional Coordinator Authored Deloitte’s national monthly 2010 – 2012 IMS HEALTH, Parsippany, NJ report on Chinese healthcare industry; Facilitated operation of a JV with Senior Analyst, Advanced Analytics distributed to 8k+ employees in Agrico in Russia. Designed workflows (2012 – 2013) Greater China. and formalized procedures creating an Analyst, Advanced Analytics (2011 – 2012) operational framework for a cross- Research Analyst, Data Investigations CAPITAL TODAY INVESTMENT, functional team of 17 people. (2009 – 2011) Shanghai, China Trading Trainee Researched client inquiries of product and Summer Investment Analyst 2008 – 2010 market trends, and managed data analysis 2011 across cross-functional teams. Worked four days a week concurrently Conducted due diligence for healthcare, with MA studies. Assisted traders with Developed resolutions for data anomalies consumer goods, and TMT companies, middle office functions: position accuracy, and created customized reports for clients which led to over $30m investment. daily P&L estimation, and contract to accurately forecast product growth and Assisted in sourcing deals. finalizations. identify sales targets.

2015 – 2016 HCIA Resume Book 23 2017 : Kim – Munch

JONATHAN KIM VICTORIA LAI YULING LEE [email protected] [email protected] [email protected] Entrepreneurship and Technology Finance Consulting and Strategy William E. Macaulay Honors College, Stanford University Nanyang Technological University The City University of New York, Stanford, California Singapore Brooklyn College BA, Human Biology, 2011 BA, Accounting, 2007 Brooklyn, New York BS, Biology, Psychology, 2006 FENOX VENTURE CAPITAL, San Jose, CA PROCTER AND GAMBLE, Singapore Pre-MBA Intern Asia Treasury Manager (2012 – 2015) COLUMBIA UNIVERSITY 2015 Senior Finance Analyst (2010 – 2012) MEDICAL CENTER, New York, NY Screened over 50 startups and influenced Led liquidity and risk management for $1b Applications Manager investment committee decisions by cash portfolio across Asia. 2013 analyzing market, regulatory, and intellectual Designed and executed debt/equity financing Managed a portfolio of applications in property risk and by preparing investment to fund working capital requirements of local the Clinical Trials Office, ranging from reports to communicate companies’ business expansion projects. electronic data capture to finance, fit with firm’s investment strategy. Led several M&A and corporate restructuring for key business operations of disparate Conducted due diligence on two health- departments. projects, including Duracell, Pet Foods care IT and telemedicine startups. divestiture. Designed and launched an institutional Quantified market size, assessed competi- research recruitment website to impact tors, and vetted management team. Pioneered team that established first ever the growth of research activities. Recommendations resulted in the firm Myanmar operations; obtained landmark investing $800k in seed capital. approval from Myanmar Central Bank. Lead Study Manager Analyst Supported ASEAN CEO/CFO in revenue 2011 – 2013 TRIAGE CONSULTING GROUP, forecasting, pricing, and other strategic Led the management of clinical trial San Francisco, CA analyses. software to assist in the collection of Senior Associate (2013 – 2015) Led and oversaw regional revenue fore- industry research funding. Associate (2011 – 2013) casting and planning activities for $1.5b Provided key financial reporting for use Trained 13 junior consultants in client revenue business across ASEAN, spanning by top level administration in managing service, database analysis, and reimburse- six countries, 15 categories, and 108 brand- research operations. ment modeling to support process country combinations. Implemented a research software improvement review of reimbursement operations across nine hospitals. Managed two direct reports in Singapore, package designed to ensure research and supervised four others in Manila. billing compliance. Negotiated with commercial payers on Project Coordinator behalf of hospital system client to resolve DELOITTE, LLP, London, United Kingdom 2009 – 2011 $60m contractual payment dispute. Senior Associate 2008 – 2010 Implemented clinical trial software Designed profitability forecasting models across the research infrastructure of the to guide project strategy and resource Advised clients of tax-efficient means of institution. allocation decisions. remuneration, including share schemes and pensions. Trained and supported research teams Led 10 guest writers across the for the software, ranging from investigators San Francisco and Atlanta offices to to administrators. produce quarterly firm-wide publication to identify trends in hospital finance Clinical Research Coordinator and analyze impact on clients. 2007 – 2009 Coordinated the conduct of both federally and industry funded clinical trials involving novel Hepatitis C treatments and immuno- suppressive therapies for transplantation. Liaised between investigator, subject, and sponsor, ensuring regulatory compliance.

24 2015 – 2016 HCIA Resume Book JAMIE MEYERSON NICHOLAS MORGAN J.T. MUNCH [email protected] [email protected] [email protected] Management and Strategy Finance and Strategy Private Equity and Management Cornell University Northwestern University Fordham University Graduate School Ithaca, New York Evanston, Illinois of Education BS, Communication, 2011 BA, Economics, 2011 New York, New York MS, Teaching, 2011 ARNHOLD GLOBAL HEALTH INSTITUTE, CR GROUP, New York, NY The Ohio State University New York, NY Private Equity Analyst Columbus, Ohio Summer Strategy Fellow 2013 – 2015 BS, Finance, 2008 2015 Member of nine-person investment Led strategy development with executive team managing $2b of debt and equity BEECKEN PETTY O’KEEFE & COMPANY, director to define institute’s vision, value investments in private and public Chicago, IL proposition, and offerings. healthcare companies. Healthcare Private Equity Associate Developed global health site engagement Evaluated more than 50 investment 2013 – 2015 strategy, cataloguing over 70 projects, opportunities under confidentiality; Completed leveraged buyouts of Paragon defining program goals, and developing site created detailed operating and investment Medical and Medical Solutions. evaluation criteria. return models to analyze prospective Engaged in industry, accounting, legal, transactions. DELOITTE CONSULTING, New York, NY and operational due diligence prior to Conducted extensive primary research Consultant (2013 – 2015) investment of capital. by interviewing industry experts, key Business Analyst (2011 – 2013) Created financial models used to derive opinion leaders, and company executives company valuations and analyze potential Led design, fielding, and analysis of to assess investment risks and merits. development finance landscape survey, investment returns. capturing $25b+ in emerging market LEERINK SWANN, San Francisco, CA Advised portfolio company management capital flows within 74 funds and facilities. Investment Banking Analyst teams on corporate finance and strategic Advised World Economic Forum 2011 – 2013 planning initiatives. Collaborative Innovation and Executed financing and advisory CENTERVIEW PARTNERS, New York, NY Biotechnology Ecosphere platforms, transactions for healthcare companies; Investment Banking Analyst co-authoring 10+ reports. focused on biopharma and medtech 2011 – 2013 Defined strategy and design of new sectors. Recommended divestiture of two business product pilot for global pharmaceutical Ranked top analyst out of class of six at segments to public board of directors; client, seeking to spark growth in post- year-end performance review. divestitures completed in 2013. patent offering. Represented senior lender group in Advised health insurance client on restructuring of water distribution company commercial implications of healthcare capital structure. reform, focused on product development and network re-contracting strategy. TEACH FOR AMERICA, New York, NY Evaluated long-term growth options for Middle School Math Teacher ancillary insurance provider, focused on 2009 – 2011 health insurance exchange benchmarking. Managed five different classes of 6th, Developed new product business case 7th, and 8th grade students at public for manufacturing client, driving $1m+ in school in South Bronx. additional sales. Drove meaningful student achievement; 72% of 6th grade students attained grade-level proficiency by end of 2011 school year.

2015 – 2016 HCIA Resume Book 25 2017 : Murphey – Richards

RICHARD MURPHEY SAM NELSON ADAM NORRIS [email protected] [email protected] [email protected] Private Equity and Entrepreneurship Strategy Consulting and Strategy Duke University Trinity College Vanderbilt University Durham, North Carolina Hartford, Connecticut Nashville, Tennessee BA, Economics, 2010 BA, Economics, 2011 BS, Economics, Human and Organizational Development, 2005 TROIA THERAPEUTICS, INC., San Diego, CA CIGNA, Newton, MA Co-Founder, Head of Operations Senior New Business Manager EPIC SYSTEMS, Verona, WI 2013 – Present 2014 – 2015 Application Auditor Oversee operations and finances, meeting Health Insurance Sales Executive for 2013 – 2015 2014 goals 50%+ under budget. companies with 250 – 5,000 employees, Identified severely overdue revenue Managed cross-functional team to prepare governments, hospitals, and universities. generation deadlines during independent for and hold pre-IND meeting. Focused on previously unexplored implementation audit. Managed customer relations while coaching project team Developed business plan, recruited distribution channels and new distributor partnership development. through successful mitigation plan and management team, and raised Series A go-live. from leading VC. CIGNA, New York, NY Pinpointed revenue bottlenecks and DIAVACS, INC., San Diego, CA Account Manager collaborated with operational leaders at NY Head of Operations 2011 – 2014 client to redistribute responsibilities; client 2014 – Present Health Insurance Account Executive for exceeded charging and payment goals within Oversee tech transfer for lead product to $65m book of business of corporate clients 60 days of go-live. Executed company-wide cGMP CMO. employing 50 – 250 employees. resolution to prevent future recurrence of similar issue. Met 1H2015 deadlines 41% under budget. Responsible for retaining and up-selling existing accounts, as well as developing Application Manager Worked with interim CEO to structure and executing on comprehensive sales 2011 – 2013 and raise Series B and revise company strategies for new prospects. strategy. Utilized and leveraged technical project Two-time Gold Circle Qualifier-Ranked as management expertise, analytical evaluations, INVESTOR GROWTH CAPITAL INC., 6th highest sales rep out of 100 national customer relationships, and team building New York, NY counterparts for final two full years in role. skills to ensure academic Colorado client Venture Capital Analyst struggling with revenue cycle billing modules 2012 – 2013 went live on time and on budget, ultimately Evaluated and executed variety of public exceeding top 10 key performance and private equity healthcare investments metrics compared to all other academic at a $1.8b AUM diversified international Epic customers. venture capital/growth equity fund. Spearheaded initiative for client mergers, acquisitions, and roll-outs, creating tools to WELLS FARGO SECURITIES, LLC, improve sales presentations, implementation Charlotte, NC processes, and enhanced delivery of client Investment Banking Analyst recommendations. 2010 – 2012 Created divisional “Success Check” Closed over a dozen debt, equity, documentation and resource tools focused on and M&A transactions in the healthcare standardizing and enforcing best practices sector. on continuous basis, leading to improved project success rates. Managed and guided eight direct reports, coaching career development.

26 2015 – 2016 HCIA Resume Book SEAN PARK VARNA RAMAN BLAKE RICHARDS [email protected] [email protected] [email protected] Strategy Consulting and Strategy Consulting University of California, Los Angeles Barnard College, Columbia University Duke University Los Angeles, California New York, New York Durham, North Carolina BS, Mathematics/Applied Science, 2010 BA, Economics, Mathematics, 2009 BS, Economics, 2011

ANTHEM, INC., Cerritos, CA VHA, New York, NY EPIC SYSTEMS, Verona, WI CareMore Member Specialist (2013 – 2015) Patient Confidentiality Lead and Actuarial Analyst II Senior Analyst (2012 – 2013) Application Manager 2013 – 2015 Analyzed $500m+ of non-labor expenses 2011 – 2015 Coordinated finance and strategy teams at NewYork-Presbyterian Hospital to Directed implementations, recommended to develop and implement Part D cost identify cost-saving opportunities across software configuration, prioritized develop- reduction strategy. The strategy was clinical and non-clinical supplies and ment, and wrote manuals to adhere to projected to reduce CareMore’s 2015 services. new privacy regulations and services in the total Part D drug cost by over 20%, or Collaborated with hospital end users to healthcare industry, including employee approximately $20m. issue RFPs and negotiate contracts for health, drug abuse, assault, psychiatry, and Conducted a statistical analysis to improve medical and surgical supplies, technology, adolescent care. the Medicare STAR rating. Analysis led and food and nutrition resulting in $1m Supervised 10 internal and customer to a rating reevaluation by CMS and a 1.5% of savings. analysts through the 12-30 month increase in total revenue for CareMore. Discovered $1m in pricing discrepancies for implementation of an electronic medical Initiated and internalized Part D Medicare purchases through pharmacy distributor; record into fully integrated enterprise bidding process from an external researched complex pharmacy regulations hospital system for up to five customers consultancy, reducing consulting expenses and collaborated with various stakeholders simultaneously, including Duke University. and turnaround time, thus increasing to resolve issue. Strategized with senior client leadership to control over annual benefit planning. Partnered with hospital purchasing develop action plans and risk mitigation to Performed quarterly experience studies department and distributor to streamline address current business challenges, and on healthcare cost trends to identify and antiquated paper-based coffee supplies reviewed agreed-upon key performance prepare against any emerging operational ordering process by converting to online indicators through the implementation and and financial risks. platform; reduced number of invoices post-live until stabilization. annually from ~500 to 12. TOWERS WATSON & CO., Irvine, CA Actuarial Analyst J.P. MORGAN, New York, NY 2011 – 2013 Analyst, Global Corporate Bank (2011 – 2012) Analyst, IB Credit Risk Management Designed a benefit evaluation model (2009 – 2011) for a healthcare client, reducing the annual project cost by over 20% while reducing Analyzed acquisition financing scenarios the margin of error. The process improve- for transactions ranging from $500m ment led to a great client satisfaction and to $2.2b to determine optimal capital solidified Towers Watson’s competitive structure. position to annually retain the client. Presented recommendations based on analyses to credit executives for transactions totaling over $10b.

2015 – 2016 HCIA Resume Book 27 2017 : Sansted – Xu

ZOE SANSTED MORGAN SHATTUCK XIN (TONY) SHU [email protected] [email protected] [email protected] Management and Operations Marketing and Management Private Equity and Corporate Development Columbia University, Claremont McKenna College Nanjing University College of Physicians and Surgeons Claremont, California Nanjing, China New York, New York BA, Chemistry, Math, 2011 MS, Chemistry, 2009 MD, 2017 Sun Yat-sen University Columbia University NORAC PHARMA, Azusa, CA Guangzhou, China New York, New York Process R&D Chemist BS, Chemistry, 2006 BA, Biophysics, 2012 2011 – 2014 Executed and documented process NORTHERN LIGHT VENTURE CAPITAL, BROOKINGS INSTITUTION, development studies in support of Beijing, China Washington, DC manufacturing and regulatory filings for Associate Intern, Center for Health Policy APIs and medical device compounds, 2012 – 2015 improving reproducibility and function 2015 – Present Sourced and executed 10 venture of the final product. Conduct research and write articles capital deals of over $65m in healthcare; pertaining to current healthcare issues, Analyzed chemical processes for cost two portfolio 10x valuation growth and with a focus on clinical transformation. effectiveness, reaction safety, and preparation for filing. chemical efficiency, including setup and Coached three portfolios to confirm next COLUMBIA STUDENT MEDICAL performance of four variable Design of round investment with over 4x valuation OUTREACH, New York, NY Experiment (DoE) models for determining growth and two acquisitions of over $30m. Clinic Coordinator (2015 – Present) process optimization. Social Work Coordinator (2013) Devised investment strategy in healthcare; Fortified positive client relationships Summer Intern (2013) collaborated with outside finance and legal over the course of five projects with firms to conduct rigorous due diligence. Manage clinic team and direct day-to-day three pharmaceutical and biotechnology operations. companies through commitment to GENERAL ELECTRIC HEALTHCARE, Created and led initiative to enroll productivity and communication, resulting Guangzhou, China uninsured patients in health insurance in over $1m in business. Product Specialist under the Affordable Care Act. Coordinated between cross-functional 2010 – 2012 Founded resource referral program. teams, from business development Strategized marketing techniques for to quality assurance, to ensure thorough $63m portfolio of interventional imaging COLUMBIA UNIVERSITY MEDICAL communication of information and on-time equipment, exceeding sales target by 22%. CENTER, New York, NY deliverables. Targeted rural markets to launch a new Research Assistant, Department of product line and brought in $18m in half Biochemistry and Molecular Biophysics KECK SCIENCE DEPARTMENT a year. 2011 OF THE CLAREMONT COLLEGES, Claremont, CA Studied the genetic basis of adult JOHNSON & JOHNSON MEDICAL, Laboratory Assistant, Organic Chemistry leg motor neuron development in Liniy, China 2010 – 2011 Drosophila melanogaster. Sales Management Trainee Completed a year-long, laboratory based Conducted, wrote, and presented 2009 – 2010 organic chemistry thesis project; presented original basic science research at Expanded market share of diabetes monitor results in a department lecture and poster CUMC and NYU. device against 10 competitors in five cities, presentation, along with a formal thesis achieving 140% sales target and attaining document. No.1 market share in three consecutive quarters.

28 2015 – 2016 HCIA Resume Book BRYAN SONG JULIAN TING JOYCE YUE XU [email protected] [email protected] [email protected] Consulting and Technology Entrepreneurship and Private Equity Strategy and Finance Tulane University School of Medicine London School of Economics Shanghai Jiaotong University New Orleans, Louisiana London, United Kingdom Shanghai, China MD, 2017 LLB, Laws, 2008 BS, Finance, 2011 Dartmouth College Hanover, New Hampshire INNOVATIVE DIAGNOSTICS, BANK OF AMERICA MERRILL LYNCH, BA, English, 2011 Hong Kong and Singapore Shanghai, China General Manager (2015) Associate, Global Corporate Banking Business Development Manager (2013 – 2015) (2014 – 2015) WELLTH, New York, NY Analyst, Global Corporate Banking MBA Intern Launched Hong Kong operations by (2011 – 2014) 2015 – Present structuring a JV with strategic partner to de-risk and accelerate project; secured Managed relationships for 26 clients, Prepared and submitted proposal for lowest costs country-wide, oversaw each with revenue of over $1b; generated a $1m NIH grant as the Principal construction of headquarters, and built 30% revenue growth. Investigator, potentially doubling the and led local team of 18. company’s funding. Led over 20 transactions as team’s Secured conversion and renewal of sole Associate and collaborated with Worked directly with the CEO and key accounts in both Singapore and Hong cross-functional global teams to CSO as the primary medical consultant, Kong ($3m+ p.a.). complete executions. performing viability research as well as competition analysis. Spearheaded regional expansion efforts Assistant to CEO of China in Hong Kong, Indonesia, and Vietnam; Pitched product with CEO directly to 2013 – 2015 developed entry strategies. insurance companies (Aetna, Cigna), Selected as assistant to CEO of China; coordinated cross-selling initiative among provider groups, and educational GRANGE PARTNERS/ASIA CAPITAL & different divisions of the bank; developed institutions. ADVISORS, Singapore China business reports and conference Executed clinical trials of product, Private Equity Associate presentations. including site visits, physician and patient 2012 – 2013 education, and analysis of collected data. Conducted extensive industry analysis Led team on “Greater China Client and financial modeling for numerous deals; Dual-Coverage” project and identified 20 BRYAN MARTIN, LLC, New Orleans, LA developed proprietary research and clients to be jointly covered by BofA Co-Founder ‘house’ views on target sectors/countries. and ML. 2013 – Present Negotiated best terms worldwide for Tracked team performance and deal Founded e-commerce lab coat business franchise rights to global fast food chain; status; assessed areas of improvement; while attending Tulane University School led deal execution. ultimately administered and monitored of Medicine; led all aspects of company ambitious, yet feasible, 20% target development and operations with HSBC PRIVATE WEALTH SOLUTIONS, growth rate in both 2013 and 2014. revenues exceeding $5k. Singapore Identified and secured manufacturer in Senior Officer BOSTON CONSULTING GROUP, El Salvador; negotiated small-batch rate, 2010 – 2012 Beijing, China Summer Associate achieving 60% profit margins. Administered trust portfolio (AUM $1.4b+); 2009 Currently negotiating with several medical increased fees by 5% through restructurings. Conducted independent research and schools to be the sponsored supplier of developed a synergy strategy between lab coats. ECM LIBRA INVESTMENT BANK, Kuala Lumpur, Malaysia client’s food and nutrition divisions. Management Associate Interviewed over 20 food processing 2008 – 2009 experts from China and US to generate Highly competitive graduate program key insights on industry dynamics, (1:35 acceptance rate); rotations through and created recommendation on near-term IBD, Equity Research, Credit, and R&D focus. Treasury.

2015 – 2016 HCIA Resume Book 29 NOTES

30 2015 – 2016 HCIA Resume Book NOTES

2015 – 2016 HCIA Resume Book 31 NOTES

32 2015 – 2016 HCIA Resume Book 2015 – 2016 HCIA Resume Book Healthcare and Pharmaceutical Management Program www8.gsb.columbia.edu/healthcare

Healthcare Industry Association (HCIA) columbiahcia.com